Cardinal Health (CAH)

With a $18.8 billion market value, Cardinal Health Inc (NYSE:CAH) ranks in the top 25% of its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader ranking places it 72 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 674 among the 782 companies in the sector, and number 4,061 in the nearly 5,000 company Portfolio Grader universe.

Currently, Cardinal Health Inc (NYSE:CAH) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. CAH has maintained this ranking for 7 months.

With a $18.4 billion market value, Cardinal Health Inc (NYSE:CAH) ranks in the top 25% of its industry group, Health Care Providers & Services, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader ranking places it 72 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 667 among the 781 companies in the sector, and number 4,088 in the nearly 5,000 company Portfolio Grader universe.

Cardinal Health Inc (NYSE:CAH) is one of 82 companies within the Health Care Providers & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. CAH's market value is $18.7 billion which places it in the top 25% of its industry group. The stock's Portfolio Grader ranking currently places it 71 among the 82 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 672 among the 782 companies in the sector, and number 4,086 in the nearly 5,000 company Portfolio Grader universe.

Currently, Cardinal Health Inc (NYSE:CAH) has a Sell using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CAH has had from Portfolio Grader for 7 months.

Cardinal Health Inc (NYSE:CAH) is a $19.6 billion in market value member of the Health Care Providers & Services GICS industry group where the stock's Portfolio Grader ranking currently places it 72 among the 82 companies in this industry group, a spot that is well below-average. CAH is ranked squarely in the bottom quartile of the sector with a ranking of 635 among the 783 companies in the sector and number 3,966 in the 5000 company Portfolio Grader company universe.

As one of the 782 companies in the GICS Health Care sector Cardinal Health Inc (NYSE:CAH) is a member of the 82 company Health Care Providers & Services GICS industry group within this sector. CAH has a market value of $21.1 billion which is in the top quarter of its industry group. The stock's current Portfolio Grader ranking places it 72 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 624 among the 782 companies in the sector, and number 3,941 in the nearly 5,000 company Portfolio Grader universe.

The current recommendation of Strong Sell for Cardinal Health Inc (NYSE:CAH) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CAH has recently seen its Portfolio Grader rating downgraded over the last month from a Sell to a Strong Sell.

Portfolio Grader currently ranks Cardinal Health Inc (NYSE:CAH) a Sell. The system for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Portfolio Grader currently ranks Cardinal Health Inc (NYSE:CAH) a Sell. The system for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.